Compare · PBAX vs SN
PBAX vs SN
Side-by-side comparison of Phoenix Biotech Acquisition Corp. (PBAX) and SharkNinja Inc. (SN): market cap, price performance, sector, and recent activity on the wire.
Summary
- PBAX operates in Industrials, while SN operates in Consumer Discretionary - the two are in different parts of the market.
- SN carries a market cap of $31.02B.
- SN has hit the wire 11 times in the past 4 weeks while PBAX has been quiet.
- SN has more recent analyst coverage (14 ratings vs 0 for PBAX).
- Company
- Phoenix Biotech Acquisition Corp.
- SharkNinja Inc.
- Price
- -
- -
- Market cap
- -
- $31.02B
- 1M return
- -
- +18.08%
- 1Y return
- -
- +141.03%
- Industry
- Consumer Electronics/Appliances
- Consumer Electronics/Appliances
- Exchange
- NASDAQ
- NYSE
- IPO
- 2021
- 2023
- News (4w)
- 0
- 11
- Recent ratings
- 0
- 14
PBAX
Phoenix Biotech Acquisition Corp.
Phoenix Biotech Acquisition Corp. intends to acquire assets and businesses through a merger, share exchange, share purchase, reorganization, or similar business combination. It focuses on pursuing opportunities in the life sciences sector. The company was incorporated in 2021 and is based in Oakland, California.
Latest PBAX
- Phoenix Biotech Acquisition Corp. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Other Events, Financial Statements and Exhibits
- Phoenix Biotech Acquisition Corp. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Change in Shell Company Status, Financial Statements and Exhibits, Leadership Update, Unregistered Sales of Equity Securities, Changes in Control of Registrant, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year (Amendment)
- New insider Corey Daniel claimed ownership of 671,470 shares (SEC Form 3) (Amendment)
- SEC Form D filed by Phoenix Biotech Acquisition Corp.
- SEC Form SC 13G/A filed by Phoenix Biotech Acquisition Corp. (Amendment)
- SEC Form 4 filed by Laporte Kathleen (Amendment)
- Atwood Brian G acquired 248,735 shares (SEC Form 4) (Amendment)
- SEC Form SC 13D/A filed by Phoenix Biotech Acquisition Corp. (Amendment)
- Loewy Caroline M acquired 5,828 shares (SEC Form 4)
- Kosacz Barbara acquired 5,828 shares (SEC Form 4)
Latest SN
- Chief Commercial Officer Shah Neil B. sold $8,938,180 worth of Ordinary Shares (40,000 units at $223.45) (SEC Form 4)
- Chief Executive Officer Barrocas Mark sold $24,999,952 worth of Ordinary Shares (113,156 units at $220.93), decreasing direct ownership by 7% to 1,565,453 units (SEC Form 4)
- Amendment: SEC Form SCHEDULE 13G/A filed by SharkNinja Inc.
- SEC Form 10-Q filed by SharkNinja Inc.
- SharkNinja Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- SharkNinja Reports Third Quarter 2026 Results
- SharkNinja Brings Its All-Star Neighbors and Fans Home for the Holidays
- SharkNinja Unveils Ninja Luxe™ Café Pro Espresso Machine by Jonathan Adler
- BTIG Research initiated coverage on SharkNinja with a new price target
- Shark Beauty Launches Limited-Edition CryoGlow LED Mask Color, Co-Designed with Kevin Hart